Phase II trial of melphalan administered via the Delcath chemosaturation system (isolated hepatic infusion) in patients with colorectal cancer metastatic to the liver and refractory to first-line systemic chemotherapy.

Trial Profile

Phase II trial of melphalan administered via the Delcath chemosaturation system (isolated hepatic infusion) in patients with colorectal cancer metastatic to the liver and refractory to first-line systemic chemotherapy.

Planning
Phase of Trial: Phase II

Latest Information Update: 05 Sep 2011

At a glance

  • Drugs Melphalan (Primary)
  • Indications Liver metastases
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Delcath Systems
  • Most Recent Events

    • 05 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top